Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

NCT00966160 ·Status: COMPLETED ·Phase: PHASE3

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

NCT00627055 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

NCT07053384 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

NCT00966329 ·Status: COMPLETED ·Phase: PHASE4

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

NCT00460746 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

NCT00415090 ·Status: COMPLETED ·Phase: PHASE4

HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance

NCT04334551 ·Status: UNKNOWN ·Phase: PHASE4

Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

NCT01814722 ·Status: TERMINATED

Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity

NCT01044810 ·Status: COMPLETED

Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD

NCT04311944 ·Status: UNKNOWN ·Phase: NA

Study of Enfuvirtide in HIV-Positive Subjects

NCT00086710 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

NCT00144248 ·Status: COMPLETED ·Phase: PHASE4

Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data

NCT01134939 ·Status: COMPLETED

An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy

NCT00193947 ·Status: TERMINATED

Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy

NCT01365065 ·Status: UNKNOWN ·Phase: PHASE2

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

NCT00075907 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

NCT00089492 ·Status: COMPLETED ·Phase: PHASE2

Structured Treatment Interruption for HIV Patients With Virologic Failure

NCT00188851 ·Status: COMPLETED ·Phase: NA

Intermittent Versus Continuous Medication in the Treatment of HIV

NCT00001967 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance

NCT04150068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

NCT05917509 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

NCT01266902 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

NCT05349838 ·Status: COMPLETED ·Phase: PHASE3

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

NCT00160849 ·Status: COMPLETED ·Phase: PHASE4

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

NCT01034917 ·Status: COMPLETED ·Phase: PHASE3